Weighted Average Number of Shares Outstanding, Basic of BridgeBio Oncology Therapeutics, Inc. from 30 Sep 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
BridgeBio Oncology Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2024 to 31 Dec 2025.
  • BridgeBio Oncology Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 79,987,399, a 337% increase year-over-year.
  • BridgeBio Oncology Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 31,144,775, a 141% increase from 2024.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

BridgeBio Oncology Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 79,987,399 +61,683,399 +337% 01 Oct 2025 31 Dec 2025 8-K 05 Mar 2026
Q3 2025 43,491,085 +43,479,996 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q4 2024 18,304,000 01 Oct 2024 31 Dec 2024 8-K 05 Mar 2026
Q3 2024 11,089* 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3

BridgeBio Oncology Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 31,144,775 +18,241,775 +141% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 12,903,000 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.